Hope for motherhood: pregnancy after allogeneic hematopoietic cell transplantation (a national multicenter study)
Blood · 2024
DOI: 10.1182/blood.2024024342 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Blood, 2024. Verfasst von Katja Sockel und 48 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, University Hospital Dresden, Technical University Dresden, Dresden, Germany. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Improved long-term survival rates after allogeneic hematopoietic cell transplantation (alloHCT) make family planning for young adult cancer survivors an important topic. However, treatment-related infertility risk poses challenges. To assess pregnancy and birth rates in a contemporary cohort, we conducted a national multicenter study using data from the German Transplant Registry, focusing on adult women aged 18 to 40 years who underwent alloHCT between 2003 and 2018. Of 2654 women who underwent transplantation, 50 women experienced 74 pregnancies, occurring at a median of 4.7 years after transplant. Fifty-seven of these resulted in live births (77%). The annual first birth rate among HCT recipients was 0.45%, which is >6 times lower than in the general population. The probability of a live birth 10 years after HCT was 3.4%. Factors associated with an increased likelihood of pregnancy were younger age at alloHCT, nonmalignant transplant indications, no total body irradiation or a cumulative dose of <8 Gy, and nonmyeloablative/reduced-intensity conditioning. Notably, 72% of pregnancies occurred spontaneously, with assisted reproductive technologies used in the remaining cases. Preterm delivery and low birth weight were more common than in the general population. This study represents the largest data set reporting pregnancies in a cohort of adult female alloHCT recipients. Our findings underscore a meaningful chance of pregnancy in alloHCT recipients. Assisted reproductive technologies techniques are important and funding should be made available. However, the potential for spontaneous pregnancies should not be underestimated, and patients should be informed of the possibility of unexpected pregnancy despite reduced fertility. Further research is warranted to understand the impact of conditioning decisions on fertility preservation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Internal Medicine I, University Hospital Dresden, Technical University Dresden, Dresden, Germany.
- Altona Children's Hospital, Hamburg, Germany.
- Department for Gynaecology and Obstetrics, University Hospital Dresden, Technical University Dresden, Dresden, Germany.
- Department of Hematology and Stem Cell Transplantation, University of Duisburg-Essen, University Hospital Essen, Essen, Germany.
- Universitätsklinikum Jena, Klinik für Innere Medizin II, Abteilung für Hämatologie und Internistische Onkologie, Jena, Germany.
- Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
ORCID-Profile: Maren Goeckenjan, Inken Hilgendorf, Friedrich Stoelzel, Wolfgang Bethge, Jürgen Finke, Uwe Platzbecker, Daniel Wolff, Christof Scheid, Stefan Klein, Igor Wolfgang Blau, Andreas Burchert, Christian Junghanss, Susann Winter, Martin Bornhaeuser, Sandra Schmeller
Zitieren
APA
Sockel, K., Neu, A., Goeckenjan, M., Ditschkowski, M., Hilgendorf, I., Kröger, N., Ayuk, F. A., Stoelzel, F., Middeke, J. M., Eder, M., Bethge, W., Finke, J., Bertz, H., Kobbe, G., Kaufmann, M., Platzbecker, U., Beverungen, D., Schmid, C., von Bonin, M., …, & Schetelig, J. (2024). Hope for motherhood: pregnancy after allogeneic hematopoietic cell transplantation (a national multicenter study). Blood. https://doi.org/10.1182/blood.2024024342
Vancouver
Sockel K, Neu A, Goeckenjan M, Ditschkowski M, Hilgendorf I, Kröger N, et al. Hope for motherhood: pregnancy after allogeneic hematopoietic cell transplantation (a national multicenter study). Blood. 2024. doi:10.1182/blood.2024024342
BibTeX
@article{Sockel2024,
author = {Sockel, Katja and Neu, Annika and Goeckenjan, Maren and Ditschkowski, Markus and Hilgendorf, Inken and Kröger, Nicolaus and Ayuk, Francis A and Stoelzel, Friedrich and Middeke, Jan Moritz and Eder, Matthias and Bethge, Wolfgang and Finke, Jürgen and Bertz, Hartmut and Kobbe, Guido and Kaufmann, Martin and Platzbecker, Uwe and Beverungen, David and Schmid, Christoph and von Bonin, Malte and Egger-Heidrich, Katharina and Heberling, Lisa and Trautmann-Grill, Karolin and Teipel, Raphael and Bug, Gesine and Tischer, Johanna and Fraccaroli, Alessia and Fante, Matthias and Wolff, Daniel and Luft, Thomas and Winkler, Julia and Schäfer-Eckart, Kerstin and Scheid, Christof and Holtick, Udo and Klein, Stefan and Blau, Igor Wolfgang and Burchert, Andreas and Wulf, Gerald and Hasenkamp, Justin and Schwerdtfeger, Rainer and Kaun, Stephan and Junghanss, Christian and Wortmann, Friederike and Winter, Susann and Neidlinger, Helga and Theuser, Catrin and Beyersmann, Jan and Bornhaeuser, Martin and Schmeller, Sandra and Schetelig, Johannes},
title = {Hope for motherhood: pregnancy after allogeneic hematopoietic cell transplantation (a national multicenter study)},
journal = {Blood},
year = {2024},
doi = {10.1182/blood.2024024342}
}
EUVIMED